Light Mode
$32.07 ↑ +0.00 (+0.00%) Trading Up from the previous close of $32.07, $0.62 below the day’s high of $32.69
+8.72 (+37.34%) / 6M
Momentum, market sentiment, and recent alerts
ARQT reads very good: price sits above both the 20- and 200-day averages, the 12-month move is +26.7%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Arcutis Biotherapeutics, Inc. engages in the development and commercialization of treatments for dermatological diseases. Its pipeline consists of topical treatments for plaque psoriasis, atopic dermatitis, hand eczema, vitiligo, scalp psoriasis, alopecia areata, and seborrheic dermatitis. The company was founded by Bhaskar Chaudhuri and David W. Osborne in June 2016 and is headquartered in Westlake Village, CA.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.